safinamide has been researched along with dinoprostone in 1 studies
| Studies (safinamide) | Trials (safinamide) | Recent Studies (post-2010) (safinamide) | Studies (dinoprostone) | Trials (dinoprostone) | Recent Studies (post-2010) (dinoprostone) |
|---|---|---|---|---|---|
| 199 | 29 | 159 | 29,105 | 1,346 | 6,357 |
| Protein | Taxonomy | safinamide (IC50) | dinoprostone (IC50) |
|---|---|---|---|
| Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | 0.0155 | |
| Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | 0.0031 | |
| Prostaglandin E2 receptor EP4 subtype | Rattus norvegicus (Norway rat) | 0.0021 | |
| Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | 0.002 | |
| Prostaglandin E2 receptor EP2 subtype | Homo sapiens (human) | 0.0087 | |
| Prostacyclin receptor | Homo sapiens (human) | 0.26 | |
| Prostaglandin E2 receptor EP2 subtype | Rattus norvegicus (Norway rat) | 0.0052 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JB; Dai, Y; Duan, QN; Huang, QX; Jin, YJ; Li, JZ; Qian, L; Sun, X | 1 |
1 other study(ies) available for safinamide and dinoprostone
| Article | Year |
|---|---|
Safinamide prevents lipopolysaccharide (LPS)-induced inflammation in macrophages by suppressing TLR4/NF-κB signaling.
Topics: Alanine; Anti-Inflammatory Agents; Benzylamines; Cyclooxygenase 2; Cytokines; Dinoprostone; Humans; Inflammation; Inflammation Mediators; Lipopolysaccharides; Macrophages; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Signal Transduction; Toll-Like Receptor 4; U937 Cells | 2021 |